tiprankstipranks
Lava Therapeutics doses first patient in Phase 1 LAVA-1266 study
PremiumThe FlyLava Therapeutics doses first patient in Phase 1 LAVA-1266 study
2M ago
LAVA Therapeutics to Transition to U.S. Domestic Issuer
Premium
Company Announcements
LAVA Therapeutics to Transition to U.S. Domestic Issuer
2M ago
Lava Therapeutics price target lowered to $2 from $6 at H.C. Wainwright
Premium
The Fly
Lava Therapeutics price target lowered to $2 from $6 at H.C. Wainwright
2M ago
LVTX Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsLVTX Upcoming Earnings Report: What to Expect?
4M ago
LAVA Therapeutics Faces Financial Hurdles
Premium
Company Announcements
LAVA Therapeutics Faces Financial Hurdles
7M ago
Lava Therapeutics reports Q2 EPS (31c) vs (48c) last year
Premium
The Fly
Lava Therapeutics reports Q2 EPS (31c) vs (48c) last year
7M ago
Lava Therapeutics reports Q1 EPS (2c) vs (53c) last year
PremiumThe FlyLava Therapeutics reports Q1 EPS (2c) vs (53c) last year
10M ago
LVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
LVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
10M ago
LAVA Therapeutics Announces Progress and Stability
Premium
Company Announcements
LAVA Therapeutics Announces Progress and Stability
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100